Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Coinbase Global Indicates $377

-Reuters

-Reuters

Total
0
Shares
Related Posts
Read More

Immutep Announced on Thursday, Successful Meeting With the FDA on Eftilagimod Alpha Plus Chemotherapy for the Treatment of Metastatic Breast Cancer

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces the results of a positive follow-up Type C meeting with the US Food and Drug Administration (FDA) regarding late-stage clinical development plans for its first-in-class soluble LAG-3 pr

IMMP